WX and HAL Rated Outperform

In Oppenheimer's Morning Research Summary both Halliburton Company HAL, and WuXi Pharmatech Inc. WX, have Outperform ratings. After attending HAL analyst meetings this week, Oppenheimer states that they "came away comfortable with our positive view of the stock (even for NAM pressure pumping for several quarters) and the potential for significantly more stock price upside." HAL closed Wednesday at $34.88 After another strong quarter from WX, Oppenheimer has raised their 2011 revenue and EPS estimates by 2.3% and 7.8% WX's price target has also increased from $18.50 to $19.00. WX closed Wednesday at $16.25.